News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,352 Results
Type
Article (10844)
Company Profile (54)
Press Release (353454)
Multimedia
Podcasts (24)
Webinars (9)
Section
Business (114500)
Career Advice (610)
Deals (21115)
Drug Delivery (49)
Drug Development (27941)
Employer Resources (55)
FDA (7980)
Job Trends (7808)
News (174429)
Policy (14108)
Tag
Academia (886)
Accelerated approval (2)
Adcomms (3)
Allergies (37)
Alliances (25304)
ALS (28)
Alzheimer's disease (504)
Antibody-drug conjugate (ADC) (31)
Approvals (8054)
Artificial intelligence (177)
Autoimmune disease (8)
Automation (6)
Bankruptcy (141)
Best Places to Work (6495)
BIOSECURE Act (4)
Biosimilars (61)
Biotechnology (38)
Bladder cancer (35)
Brain cancer (10)
Breast cancer (128)
Cancer (919)
Cardiovascular disease (81)
Career advice (533)
Career pathing (4)
CAR-T (47)
Cell therapy (165)
Cervical cancer (9)
Clinical research (23582)
Collaboration (394)
Compensation (191)
Complete response letters (4)
COVID-19 (937)
CRISPR (17)
C-suite (169)
Cystic fibrosis (33)
Data (1053)
Decentralized trials (1)
Denatured (10)
Depression (17)
Diabetes (125)
Diagnostics (4188)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (18)
Drug discovery (44)
Drug pricing (49)
Drug shortages (6)
Duchenne muscular dystrophy (42)
Earnings (49640)
Editorial (18)
Employer branding (6)
Employer resources (52)
Events (70252)
Executive appointments (497)
FDA (8651)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (384)
Gene editing (34)
Generative AI (19)
Gene therapy (110)
GLP-1 (260)
Government (1623)
Grass and pollen (2)
Guidances (43)
Healthcare (11496)
Huntington's disease (3)
IgA nephropathy (14)
Immunology and inflammation (27)
Indications (18)
Infectious disease (997)
Inflammatory bowel disease (56)
Inflation Reduction Act (5)
Influenza (18)
Intellectual property (31)
Interviews (68)
IPO (10012)
IRA (16)
Job creations (1589)
Job search strategy (487)
Kidney cancer (8)
Labor market (8)
Layoffs (162)
Leadership (5)
Legal (3505)
Liver cancer (31)
Lung cancer (110)
Lymphoma (65)
Machine learning (3)
Management (20)
Manufacturing (114)
MASH (39)
Medical device (8162)
Medtech (8163)
Mergers & acquisitions (11491)
Metabolic disorders (318)
Multiple sclerosis (40)
NASH (10)
Neurodegenerative disease (25)
Neuropsychiatric disorders (8)
Neuroscience (702)
NextGen: Class of 2025 (3810)
Non-profit (2031)
Now hiring (5)
Obesity (159)
Opinion (86)
Ovarian cancer (31)
Pain (31)
Pancreatic cancer (26)
Parkinson's disease (45)
Partnered (9)
Patents (53)
Patient recruitment (59)
Peanut (22)
People (34710)
Pharmaceutical (16)
Pharmacy benefit managers (9)
Phase I (6366)
Phase II (9621)
Phase III (9141)
Pipeline (784)
Policy (50)
Postmarket research (1136)
Preclinical (2380)
Press Release (67)
Prostate cancer (49)
Psychedelics (6)
Radiopharmaceuticals (151)
Rare diseases (161)
Real estate (2831)
Recruiting (18)
Regulatory (9926)
Reports (20)
Research institute (818)
Resumes & cover letters (83)
Rett syndrome (5)
RNA editing (1)
RSV (17)
Schizophrenia (33)
Series A (58)
Series B (50)
Service/supplier (3)
Sickle cell disease (28)
Special edition (6)
Spinal muscular atrophy (61)
Sponsored (10)
Startups (1851)
Stomach cancer (3)
Supply chain (28)
Tariffs (14)
The Weekly (14)
Vaccines (189)
Venture capitalists (18)
Weight loss (80)
Women's health (21)
Worklife (2)
Date
Today (87)
Last 7 days (442)
Last 30 days (1308)
Last 365 days (17997)
2025 (6110)
2024 (19313)
2023 (21923)
2022 (30507)
2021 (32842)
2020 (32084)
2019 (25870)
2018 (19466)
2017 (16198)
2016 (15739)
2015 (19401)
2014 (14997)
2013 (12304)
2012 (13031)
2011 (13429)
2010 (12346)
Location
Africa (361)
Alabama (25)
Alaska (3)
Arizona (110)
Arkansas (7)
Asia (18843)
Australia (2639)
California (3245)
Canada (1130)
China (209)
Colorado (163)
Connecticut (149)
Delaware (70)
Europe (43099)
Florida (505)
Georgia (111)
Hawaii (1)
Idaho (38)
Illinois (306)
India (21)
Indiana (186)
Iowa (3)
Japan (123)
Kansas (40)
Kentucky (17)
Louisiana (9)
Maine (62)
Maryland (391)
Massachusetts (2540)
Michigan (134)
Minnesota (232)
Mississippi (2)
Missouri (61)
Montana (20)
Nebraska (17)
Nevada (35)
New Hampshire (35)
New Jersey (1058)
New Mexico (10)
New York (950)
North Carolina (604)
North Dakota (4)
Northern California (1504)
Ohio (105)
Oklahoma (9)
Oregon (14)
Pennsylvania (751)
Puerto Rico (4)
Rhode Island (15)
South America (509)
South Carolina (10)
Southern California (1201)
Tennessee (75)
Texas (400)
United States (12710)
Utah (142)
Virginia (77)
Washington D.C. (33)
Washington State (289)
West Virginia (3)
Wisconsin (44)
364,352 Results for "tenet healthcare corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation
The Regents of the University of California, on behalf of the University of California, Irvine, has entered into a definitive agreement with Tenet Healthcare Corporation to acquire Tenet’s Pacific Coast Network.
February 1, 2024
·
6 min read
Deals
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics, Inc. (Nasdaq: ELYM) (“Eliem”), today announced the closing of its acquisition with Tenet Medicines (“Tenet”).
June 27, 2024
·
11 min read
Deals
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics, Inc. and Tenet Medicines, Inc., a development-stage private biotechnology company, announced that the companies have entered into a definitive acquisition agreement whereby Eliem has agreed to acquire Tenet.
April 11, 2024
·
14 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
Waters Corporation to Present at the Leerink Partners Global Healthcare Conference
March 10, 2025
·
1 min read
Press Releases
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
March 4, 2025
·
2 min read
Press Releases
Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
January 22, 2025
·
2 min read
Press Releases
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
January 22, 2025
·
3 min read
IN PARTNERSHIP WITH DIA
Beyond Neutrality: How Nonprofit Organizations Drive Healthcare Innovation and Collaboration
Health-focused nonprofits like the Drug Information Association (DIA) serve as crucial bridge-builders in the healthcare ecosystem during a time of uncertainty.
April 7, 2025
·
7 min read
·
BioSpace Insights
Press Releases
Humanetics Corporation Chief Medical Officer Is Featured Guest at U.S. Industry, National Security, and Healthcare Forum
February 25, 2025
·
2 min read
1 of 36,436
Next
